Google
Apple
English (UK)
English (Canada)
Deutsch (Deutschland)
Deutsch (Schweiz)
Español
Français (France)
Italiano
Nederlands (Nederland)
Nederlands (België)
GILEAD SCIENCES, INC. |
Market Closed -
Other stock markets
|
|
5-day change | 1st Jan Change | |
| 77.66 USD | +1.38% | +3.01% | -9.55% | |
| Nov. 30 | Wall Street: ideal end to the session, perfect November | CF |
| Nov. 29 | Amazon: 'Black Friday' and 're:Invent' support the stock | CF |
Valuation
| Fiscal Period : December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Capitalization 1 | 80 916 | 82 209 | 73 031 | 91 081 | 107 677 | 96 755 | - | - |
| Enterprise Value (EV) 1 | 78 449 | 82 450 | 103 910 | 118 530 | 126 522 | 111 518 | 106 537 | 100 637 |
| P/E ratio | 15,0x | 15,4x | 583x | 14,7x | 23,6x | 16,5x | 14,3x | 13,6x |
| Yield | 3,65% | 3,88% | 4,67% | 3,91% | 3,40% | 3,89% | 4,09% | 4,28% |
| Capitalization / Revenue | 3,66x | 3,66x | 2,96x | 3,34x | 3,95x | 3,58x | 3,50x | 3,42x |
| EV / Revenue | 3,55x | 3,67x | 4,21x | 4,34x | 4,64x | 4,12x | 3,86x | 3,56x |
| EV / EBITDA | 6,11x | 6,61x | 7,88x | 8,12x | 8,86x | 8,53x | 7,57x | 6,90x |
| EV / FCF | 10,5x | 9,91x | 13,8x | 11,0x | 15,2x | 12,5x | 11,3x | 10,4x |
| FCF Yield | 9,53% | 10,1% | 7,24% | 9,12% | 6,59% | 8,02% | 8,88% | 9,60% |
| Price to Book | 3,75x | 3,65x | 4,04x | 4,32x | 5,05x | 4,24x | 3,80x | 3,42x |
| Nbr of stocks (in thousands) | 1 293 620 | 1 265 146 | 1 253 528 | 1 254 384 | 1 254 244 | 1 246 042 | - | - |
| Reference price 2 | 62,6 | 65,0 | 58,3 | 72,6 | 85,9 | 77,7 | 77,7 | 77,7 |
| Announcement Date | 02/04/19 | 02/04/20 | 02/04/21 | 02/01/22 | 02/02/23 | - | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period : December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 22 127 | 22 449 | 24 689 | 27 305 | 27 281 | 27 053 | 27 611 | 28 300 |
| EBITDA 1 | 12 840 | 12 468 | 13 184 | 14 598 | 14 283 | 13 071 | 14 065 | 14 576 |
| EBIT 1 | 11 411 | 11 064 | 11 704 | 12 548 | 12 180 | 10 721 | 11 729 | 12 019 |
| Operating Margin | 51,6% | 49,3% | 47,4% | 46,0% | 44,6% | 39,6% | 42,5% | 42,5% |
| Earnings before Tax (EBT) 1 | 7 799 | 5 160 | 1 669 | 8 278 | 5 814 | 7 328 | 8 417 | 8 767 |
| Net income 1 | 5 455 | 5 386 | 123 | 6 225 | 4 592 | 5 887 | 6 658 | 7 035 |
| Net margin | 24,7% | 24,0% | 0,50% | 22,8% | 16,8% | 21,8% | 24,1% | 24,9% |
| EPS 2 | 4,17 | 4,22 | 0,10 | 4,93 | 3,64 | 4,70 | 5,42 | 5,72 |
| Free Cash Flow 1 | 7 476 | 8 319 | 7 518 | 10 805 | 8 344 | 8 942 | 9 463 | 9 659 |
| FCF margin | 33,8% | 37,1% | 30,5% | 39,6% | 30,6% | 33,1% | 34,3% | 34,1% |
| FCF Conversion (EBITDA) | 58,2% | 66,7% | 57,0% | 74,0% | 58,4% | 68,4% | 67,3% | 66,3% |
| FCF Conversion (Net income) | 137% | 154% | 6 112% | 174% | 182% | 152% | 142% | 137% |
| Dividend per Share 2 | 2,28 | 2,52 | 2,72 | 2,84 | 2,92 | 3,02 | 3,18 | 3,32 |
| Announcement Date | 04/02/19 | 04/02/20 | 04/02/21 | 01/02/22 | 02/02/23 | - | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period : December | 2021 Q2 | 2021 Q3 | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 6 217 | 7 421 | 7 244 | 6 590 | 6 260 | 7 042 | 7 389 | 6 352 | 6 599 | 7 051 | 7 071 | 6 478 | 6 823 | 7 066 | 7 329 |
| EBITDA 1 | 3 695 | 4 902 | 2 042 | 4 049 | 3 195 | 3 811 | 3 227 | 2 883 | 3 258 | 3 908 | 3 558 | - | - | - | - |
| EBIT 1 | 3 176 | 4 379 | 1 507 | 3 524 | 2 670 | 3 286 | 2 699 | 2 243 | 2 277 | 3 224 | 2 964 | 2 959 | 3 056 | 3 327 | 3 018 |
| Operating Margin | 51,1% | 59,0% | 20,8% | 53,5% | 42,7% | 46,7% | 36,5% | 35,3% | 34,5% | 45,7% | 41,9% | 45,7% | 44,8% | 47,1% | 41,2% |
| Earnings before Tax (EBT) 1 | 1 817 | 3 438 | 759 | -152 | 1 503 | 2 432 | 2 031 | 1 300 | 1 588 | 2 318 | 2 090 | 2 094 | 1 914 | 2 315 | 2 218 |
| Net income 1 | 1 522 | 2 592 | 382 | 19,0 | 1 144 | 1 789 | 1 640 | 1 010 | 1 045 | 2 180 | 1 629 | 1 565 | 1 660 | 1 878 | 2 011 |
| Net margin | 24,5% | 34,9% | 5,27% | 0,29% | 18,3% | 25,4% | 22,2% | 15,9% | 15,8% | 30,9% | 23,0% | 24,2% | 24,3% | 26,6% | 27,4% |
| EPS 2 | 1,21 | 2,05 | 0,30 | 0,02 | 0,91 | 1,42 | 1,30 | 0,80 | 0,83 | 1,73 | 1,29 | 1,33 | 1,43 | 1,63 | 1,40 |
| Dividend per Share 2 | 0,71 | 0,71 | 0,71 | 0,73 | 0,73 | 0,73 | 0,73 | 0,75 | 0,75 | 0,75 | 0,75 | 0,74 | 0,74 | 0,74 | 0,74 |
| Announcement Date | 07/29/21 | 10/28/21 | 02/01/22 | 04/28/22 | 08/02/22 | 10/27/22 | 02/02/23 | 04/27/23 | 08/03/23 | 11/07/23 | - | - | - | - | - |
1USD in Million2USD
Estimates
Balance Sheet Analysis
| Fiscal Period : December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Net Debt 1 | - | 241 | 30 879 | 27 449 | 18 845 | 14 763 | 9 782 | 3 882 |
| Net Cash position 1 | 2 467 | - | - | - | - | - | - | - |
| Leverage (Debt/EBITDA) | - | 0,02x | 2,34x | 1,88x | 1,32x | 1,13x | 0,70x | 0,27x |
| Free Cash Flow 1 | 7 476 | 8 319 | 7 518 | 10 805 | 8 344 | 8 942 | 9 463 | 9 659 |
| ROE (net income / shareholders' equity) | 41,5% | 38,3% | 43,8% | 46,8% | 43,3% | 38,1% | 34,4% | 31,9% |
| Shareholders' equity 1 | 13 136 | 14 055 | 281 | 13 305 | 10 598 | 15 437 | 19 351 | 22 035 |
| ROA (Net income/ Total Assets) | 8,14% | 8,60% | 0,19% | 9,13% | 14,0% | 10,5% | 11,7% | 11,7% |
| Assets 1 | 66 979 | 62 651 | 65 079 | 68 180 | 32 874 | 55 807 | 56 958 | 60 286 |
| Book Value Per Share 2 | 16,7 | 17,8 | 14,4 | 16,8 | 17,0 | 18,3 | 20,4 | 22,7 |
| Cash Flow per Share 2 | 6,42 | 7,16 | 6,47 | 9,02 | 7,19 | 7,04 | 7,34 | 7,83 |
| Capex 1 | 924 | 825 | 650 | 579 | 728 | 685 | 711 | 727 |
| Capex / Sales | 4,18% | 3,67% | 2,63% | 2,12% | 2,67% | 2,53% | 2,57% | 2,57% |
| Announcement Date | 02/04/19 | 02/04/20 | 02/04/21 | 02/01/22 | 02/02/23 | - | - | - |
1USD in Million2USD
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
Trading Rating :
Investor Rating :
ESG Refinitiv :
B-
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
32
Last Close Price
77.65USD
Average target price
90.39USD
Spread / Average Target
+16.41%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -9.55% | 96 755 M $ | |
| +59.64% | 525 B $ | |
| +48.98% | 454 B $ | |
| -10.34% | 381 B $ | |
| -11.26% | 253 B $ | |
| -17.52% | 221 B $ | |
| +2.14% | 202 B $ | |
| -9.09% | 200 B $ | |
| -43.58% | 163 B $ | |
| +3.74% | 146 B $ |
- Stock
- Equities
- Stock Gilead Sciences, Inc. - Nasdaq
- Financials Gilead Sciences, Inc.
